Literature DB >> 35832958

Residual Tumor Volume and Tumor Progression after Subtotal Resection and Observation of WHO Grade I Skull Base Meningiomas.

Colin J Przybylowski1, Benjamin K Hendricks1, Charuta G Furey1, Joseph D DiDomenico1, Randall W Porter1, Nader Sanai1, Kaith K Almefty1, Andrew S Little1.   

Abstract

Objective  This study investigated the impact of residual tumor volume (RTV) on tumor progression after subtotal resection and observation of WHO grade I skull base meningiomas. Study Design  This study is a retrospective volumetric analysis. Setting  This study was conducted at a single institution. Participants  Patients who underwent subtotal resection of a WHO grade I skull base meningioma and postsurgical observation (July 1, 2007-July 1, 2017). Main Outcome Measure  The main outcome was radiographic tumor progression. Results  Sixty patients with residual skull base meningiomas were analyzed. The median (interquartile range) RTV was 1.3 (5.3) cm 3 . Tumor progression occurred in 23 patients (38.3%) at a mean duration of 28.6 months postsurgery. The 1-, 3-, and 5-year actuarial progression-free survival (PFS) rates were 98.3, 58.6, and 48.7%, respectively. The Cox multivariate analysis identified increasing RTV ( p  = 0.01) and history of more than 1 previous surgery ( p  = 0.03) as independent predictors of tumor progression. In a Kaplan-Meier analysis for PFS, the RTV threshold of 3 cm 3 maximized log-rank testing significance between groups of patients dichotomized at 0.5 cm 3 thresholds ( p  < 0.01). The 3-year actuarial PFS rates for meningiomas with RTV ≤3 cm 3 and >3 cm 3 were 76.2 and 32.1%, respectively. When RTV >3 cm 3 was entered as a covariate in the Cox model, it was the only factor independently associated with tumor progression ( p  < 0.01). Conclusion  RTV was associated with tumor progression after subtotal resection of WHO grade I skull base meningioma in this cohort. An RTV threshold of 3 cm 3 was identified that minimized progression of the residual tumor when gross total resection was not safe or feasible. Thieme. All rights reserved.

Entities:  

Keywords:  meningioma; progression; recurrence; residual; skull base; tumor

Year:  2021        PMID: 35832958      PMCID: PMC9272298          DOI: 10.1055/s-0041-1733974

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  17 in total

1.  Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.

Authors:  Anil Nanda; Shyamal C Bir; Tanmoy K Maiti; Subhas K Konar; Symeon Missios; Bharat Guthikonda
Journal:  J Neurosurg       Date:  2016-04-08       Impact factor: 5.115

2.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Authors:  Felix Sahm; Daniel Schrimpf; Damian Stichel; David T W Jones; Thomas Hielscher; Sebastian Schefzyk; Konstantin Okonechnikov; Christian Koelsche; David E Reuss; David Capper; Dominik Sturm; Hans-Georg Wirsching; Anna Sophie Berghoff; Peter Baumgarten; Annekathrin Kratz; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Hayley P Ellis; Kathreena M Kurian; Ali Fuat Okuducu; Christine Jungk; Katharina Drueschler; Matthias Schick; Melanie Bewerunge-Hudler; Christian Mawrin; Marcel Seiz-Rosenhagen; Ralf Ketter; Matthias Simon; Manfred Westphal; Katrin Lamszus; Albert Becker; Arend Koch; Jens Schittenhelm; Elisabeth J Rushing; V Peter Collins; Stefanie Brehmer; Lukas Chavez; Michael Platten; Daniel Hänggi; Andreas Unterberg; Werner Paulus; Wolfgang Wick; Stefan M Pfister; Michel Mittelbronn; Matthias Preusser; Christel Herold-Mende; Michael Weller; Andreas von Deimling
Journal:  Lancet Oncol       Date:  2017-03-15       Impact factor: 41.316

Review 3.  Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.

Authors:  Amey R Savardekar; Devi Prasad Patra; Shyamal Bir; Jai Deep Thakur; Nasser Mohammed; Papireddy Bollam; Maria-Magdalena Georgescu; Anil Nanda
Journal:  World Neurosurg       Date:  2017-12-16       Impact factor: 2.104

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

5.  The role of radical microsurgical resection in multimodal treatment for skull base meningioma.

Authors:  Tsutomu Ichinose; Takeo Goto; Kenichi Ishibashi; Toshihiro Takami; Kenji Ohata
Journal:  J Neurosurg       Date:  2010-03-12       Impact factor: 5.115

6.  Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas.

Authors:  Theo L Winther; Sverre H Torp
Journal:  World Neurosurg       Date:  2016-11-17       Impact factor: 2.104

7.  Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.

Authors:  Joshua Materi; David Mampre; Jeff Ehresman; Jordina Rincon-Torroella; Kaisorn L Chaichana
Journal:  J Neurosurg       Date:  2020-01-03       Impact factor: 5.115

8.  Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.

Authors:  Ümmügülsüm Yesilöz; Elmar Kirches; Christian Hartmann; Johannes Scholz; Siegfried Kropf; Felix Sahm; Makoto Nakamura; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

9.  Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity.

Authors:  Zsolt Zador; Alexander P Landry; Michael Balas; Michael D Cusimano
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.